https://www.pharmaceutical-technology.com/news/newsfda-grants-orphan-status-amarantus-eltoprazine-treat-pd-lid-4807378/
The US Food and Drug Administration (FDA) has granted orphan drug designation for Amarantus BioScience Holdings' (AMBS') eltoprazine to treat Parkinson's...
orphan statusfdagrantsamarantuseltoprazine